{"ticker": "MYMD", "overview": {"cik": "1321834", "ticker": "QCLS", "name": "Q/C TECHNOLOGIES, INC.", "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "sic": "2835", "announcements": [{"form": "3", "date": "2026-08-17", "title": "Initial insider holdings", "accession": "0001493152-26-038855", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-12", "title": "Quarterly report", "accession": "0001493152-26-037333", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001493152-26-031946", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001493152-26-023751", "price_sensitive": true}, {"form": "4", "date": "2026-05-14", "title": "Insider transaction", "accession": "0001493152-26-023217", "price_sensitive": false}, {"form": "10-K/A", "date": "2026-04-29", "title": "Form 10-K/A", "accession": "0001493152-26-019663", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016913", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016910", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016914", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016911", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016912", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016909", "price_sensitive": false}, {"form": "10-K", "date": "2026-04-15", "title": "Annual report", "accession": "0001493152-26-016872", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-03-31", "title": "Form NT 10-K", "accession": "0001493152-26-014222", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-13", "title": "Material event", "accession": "0001493152-26-010070", "price_sensitive": true}, {"form": "EFFECT", "date": "2026-02-17", "title": "Form EFFECT", "accession": "9999999995-26-000618", "price_sensitive": false}, {"form": "CORRESP", "date": "2026-02-12", "title": "Form CORRESP", "accession": "0001493152-26-006490", "price_sensitive": false}, {"form": "S-3", "date": "2026-02-11", "title": "Shelf registration", "accession": "0001493152-26-006234", "price_sensitive": false}, {"form": "4", "date": "2026-01-30", "title": "Insider transaction", "accession": "0001493152-26-004565", "price_sensitive": false}, {"form": "3", "date": "2026-01-30", "title": "Initial insider holdings", "accession": "0001493152-26-004564", "price_sensitive": false}, {"form": "UPLOAD", "date": "2026-01-28", "title": "Form UPLOAD", "accession": "0000000000-26-001037", "price_sensitive": false}, {"form": "8-K", "date": "2026-01-23", "title": "Material event", "accession": "0001493152-26-003440", "price_sensitive": true}, {"form": "DRS", "date": "2026-01-23", "title": "Form DRS", "accession": "0001493152-26-003372", "price_sensitive": false}, {"form": "8-K", "date": "2025-12-09", "title": "Material event", "accession": "0001493152-25-026798", "price_sensitive": true}, {"form": "424B3", "date": "2025-12-01", "title": "Form 424B3", "accession": "0001493152-25-025610", "price_sensitive": false}]}, "description": "", "exchange": null, "stats": {"buy_n": 5, "buy_sum": 403687.6636, "sell_n": 0, "sell_sum": 0, "net": 403687.6636, "insiders": 2, "first_date": "2021-11-23", "last_date": "2023-08-24"}, "metrics": {"ticker": "MYMD", "has_prices": false}, "trades": [{"id": "0001493152-23-030111", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "Chief Legal Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 166500.00000000003, "score": 54.4, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "An exec goes shopping: $167K of MYMD", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223030111/0001493152-23-030111-index.htm", "trade_date": "2023-08-24", "timestamp": "2023-08-24", "mins": 1679921}, {"id": "0001493152-23-029445", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "Chief Legal Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 28080.0, "score": 38.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "C-suite exec buys $28K of MYMD", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223029445/0001493152-23-029445-index.htm", "trade_date": "2023-08-17", "timestamp": "2023-08-17", "mins": 1690001}, {"id": "0001493152-23-020794", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Billy Joe White", "who_key": "White Billy Joe", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020794/0001493152-23-020794-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020800", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "Chief Legal Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "C-suite exec files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020800/0001493152-23-020800-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020797", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Craig Eagle", "who_key": "EAGLE CRAIG", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020797/0001493152-23-020797-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020798", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020798/0001493152-23-020798-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020796", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Schreiber", "who_key": "Schreiber Christopher C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020796/0001493152-23-020796-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020799", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Jude Uzonwanne", "who_key": "Uzonwanne Jude", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020799/0001493152-23-020799-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020793", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Adam Kaplin", "who_key": "Kaplin Adam", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "C-suite exec files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020793/0001493152-23-020793-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-020795", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Chapman Jr", "who_key": "Chapman Christopher C JR", "role": "President, Chief Med. Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223020795/0001493152-23-020795-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792241}, {"id": "0001493152-23-011040", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Chapman Jr", "who_key": "Chapman Christopher C JR", "role": "President, Chief Med. Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223011040/0001493152-23-011040-index.htm", "trade_date": "2023-04-04", "timestamp": "2023-04-04", "mins": 1884401}, {"id": "0001493152-22-034969", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "EVP of Operations, GC", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 15300.0, "score": 25.2, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Someone inside MYMD is buying \u2014 $15K worth", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315222034969/0001493152-22-034969-index.htm", "trade_date": "2022-12-08", "timestamp": "2022-12-08", "mins": 2052881}, {"id": "0001493152-21-029973", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 103357.6636, "score": 40.6, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "A director backs MYMD with $103K", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/0001493152-21-029973-index.htm", "trade_date": "2021-11-26", "timestamp": "2021-11-26", "mins": 2595761}, {"id": "0001493152-21-029774", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "EVP of Operations, GC", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 90450.0, "score": 34.7, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider cluster: 3 buying MYMD", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029774/0001493152-21-029774-index.htm", "trade_date": "2021-11-23", "timestamp": "2021-11-23", "mins": 2600081}, {"id": "0001493152-21-025600", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "EVP of Operations, GC", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025600/0001493152-21-025600-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025601", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Chapman Jr", "who_key": "Chapman Christopher C JR", "role": "President, Chief Med. Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025601/0001493152-21-025601-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025602", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025602/0001493152-21-025602-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025605", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Craig Eagle", "who_key": "EAGLE CRAIG", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025605/0001493152-21-025605-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025606", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Jude Uzonwanne", "who_key": "Uzonwanne Jude", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025606/0001493152-21-025606-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025608", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Billy Joe White", "who_key": "White Billy Joe", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025608/0001493152-21-025608-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025609", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Schreiber", "who_key": "Schreiber Christopher C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025609/0001493152-21-025609-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-025613", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Adam Kaplin", "who_key": "Kaplin Adam", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "C-suite exec files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221025613/0001493152-21-025613-index.htm", "trade_date": "2021-10-14", "timestamp": "2021-10-14", "mins": 2657681}, {"id": "0001493152-21-009291", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Billy Joe White", "who_key": "White Billy Joe", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 189325.50000000003, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009291/0001493152-21-009291-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009294", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 189325.50000000003, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/0001493152-21-009294-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009297", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Robert C. Schroeder", "who_key": "SCHROEDER ROBERT C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 72588.36, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009297/0001493152-21-009297-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009302", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "EVP of Operations, GC", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009302/0001493152-21-009302-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009385", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Chapman Jr", "who_key": "Chapman Christopher C JR", "role": "President, Chief Med. Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/0001493152-21-009385-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009387", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Jude Uzonwanne", "who_key": "Uzonwanne Jude", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009387/0001493152-21-009387-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009398", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Christopher C. Schreiber", "who_key": "Schreiber Christopher C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 227798.22000000003, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/0001493152-21-009398-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}, {"id": "0001493152-21-009409", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Adam Kaplin", "who_key": "Kaplin Adam", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "C-suite exec files routine paperwork on MYMD \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221009409/0001493152-21-009409-index.htm", "trade_date": "2021-04-16", "timestamp": "2021-04-16", "mins": 2918321}], "recent_buys": [{"id": "0001493152-23-030111", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "Chief Legal Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 166500.00000000003, "score": 54.4, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "An exec goes shopping: $167K of MYMD", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223030111/0001493152-23-030111-index.htm", "trade_date": "2023-08-24", "timestamp": "2023-08-24", "mins": 1679921}, {"id": "0001493152-23-029445", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "Chief Legal Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 28080.0, "score": 38.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "C-suite exec buys $28K of MYMD", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223029445/0001493152-23-029445-index.htm", "trade_date": "2023-08-17", "timestamp": "2023-08-17", "mins": 1690001}, {"id": "0001493152-22-034969", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "EVP of Operations, GC", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 15300.0, "score": 25.2, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Someone inside MYMD is buying \u2014 $15K worth", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315222034969/0001493152-22-034969-index.htm", "trade_date": "2022-12-08", "timestamp": "2022-12-08", "mins": 2052881}, {"id": "0001493152-21-029973", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 103357.6636, "score": 40.6, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "A director backs MYMD with $103K", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/0001493152-21-029973-index.htm", "trade_date": "2021-11-26", "timestamp": "2021-11-26", "mins": 2595761}, {"id": "0001493152-21-029774", "src": "INSIDERS", "ticker": "MYMD", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "MyMD Pharmaceuticals, Inc.", "who": "Paul Rivard", "who_key": "Rivard Paul", "role": "EVP of Operations, GC", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 90450.0, "score": 34.7, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider cluster: 3 buying MYMD", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029774/0001493152-21-029774-index.htm", "trade_date": "2021-11-23", "timestamp": "2021-11-23", "mins": 2600081}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Paul Rivard", "who_key": "Rivard Paul", "role": "Chief Legal Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 300330.0, "sold": 0, "net": 300330.0, "trades": 4, "top_score": 54.4, "lean": "buying", "history": [{"action": "BUY", "amount": 166500.00000000003, "date": "2023-08-24", "score": 54.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223030111/0001493152-23-030111-index.htm"}, {"action": "BUY", "amount": 28080.0, "date": "2023-08-17", "score": 38.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223029445/0001493152-23-029445-index.htm"}, {"action": "BUY", "amount": 15300.0, "date": "2022-12-08", "score": 25.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315222034969/0001493152-22-034969-index.htm"}, {"action": "BUY", "amount": 90450.0, "date": "2021-11-23", "score": 34.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029774/0001493152-21-029774-index.htm"}], "latest": {"action": "BUY", "amount": 166500.00000000003, "date": "2023-08-24", "score": 54.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315223030111/0001493152-23-030111-index.htm"}}, {"who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 103357.6636, "sold": 0, "net": 103357.6636, "trades": 1, "top_score": 40.6, "lean": "buying", "history": [{"action": "BUY", "amount": 103357.6636, "date": "2021-11-26", "score": 40.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/0001493152-21-029973-index.htm"}], "latest": {"action": "BUY", "amount": 103357.6636, "date": "2021-11-26", "score": 40.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/0001493152-21-029973-index.htm"}}], "activity": [], "announcements": [{"form": "3", "date": "2026-08-17", "title": "Initial insider holdings", "accession": "0001493152-26-038855", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-12", "title": "Quarterly report", "accession": "0001493152-26-037333", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001493152-26-031946", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001493152-26-023751", "price_sensitive": true}, {"form": "4", "date": "2026-05-14", "title": "Insider transaction", "accession": "0001493152-26-023217", "price_sensitive": false}, {"form": "10-K/A", "date": "2026-04-29", "title": "Form 10-K/A", "accession": "0001493152-26-019663", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016913", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016910", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016914", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016911", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016912", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016909", "price_sensitive": false}, {"form": "10-K", "date": "2026-04-15", "title": "Annual report", "accession": "0001493152-26-016872", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-03-31", "title": "Form NT 10-K", "accession": "0001493152-26-014222", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-13", "title": "Material event", "accession": "0001493152-26-010070", "price_sensitive": true}, {"form": "EFFECT", "date": "2026-02-17", "title": "Form EFFECT", "accession": "9999999995-26-000618", "price_sensitive": false}, {"form": "CORRESP", "date": "2026-02-12", "title": "Form CORRESP", "accession": "0001493152-26-006490", "price_sensitive": false}, {"form": "S-3", "date": "2026-02-11", "title": "Shelf registration", "accession": "0001493152-26-006234", "price_sensitive": false}, {"form": "4", "date": "2026-01-30", "title": "Insider transaction", "accession": "0001493152-26-004565", "price_sensitive": false}, {"form": "3", "date": "2026-01-30", "title": "Initial insider holdings", "accession": "0001493152-26-004564", "price_sensitive": false}, {"form": "UPLOAD", "date": "2026-01-28", "title": "Form UPLOAD", "accession": "0000000000-26-001037", "price_sensitive": false}, {"form": "8-K", "date": "2026-01-23", "title": "Material event", "accession": "0001493152-26-003440", "price_sensitive": true}, {"form": "DRS", "date": "2026-01-23", "title": "Form DRS", "accession": "0001493152-26-003372", "price_sensitive": false}, {"form": "8-K", "date": "2025-12-09", "title": "Material event", "accession": "0001493152-25-026798", "price_sensitive": true}, {"form": "424B3", "date": "2025-12-01", "title": "Form 424B3", "accession": "0001493152-25-025610", "price_sensitive": false}], "performance": {"ticker": "MYMD", "has_prices": false, "summary": null, "buys": [{"who": "Rivard Paul", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Legal Officer", "amount": 166500.00000000003, "date": "2023-08-24", "score": 54.4, "ref_price": null, "return": null}, {"who": "Rivard Paul", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Legal Officer", "amount": 28080.0, "date": "2023-08-17", "score": 38.0, "ref_price": null, "return": null}, {"who": "Rivard Paul", "person_type": "EXEC", "person_label": "Execs", "role": "EVP of Operations, GC", "amount": 15300.0, "date": "2022-12-08", "score": 25.2, "ref_price": null, "return": null}, {"who": "Silverman Joshua", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 103357.6636, "date": "2021-11-26", "score": 40.6, "ref_price": null, "return": null}, {"who": "Rivard Paul", "person_type": "EXEC", "person_label": "Execs", "role": "EVP of Operations, GC", "amount": 90450.0, "date": "2021-11-23", "score": 34.7, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}